Harwell’s clients have included former San Francisco 49ers owner Eddie DeBartolo in numerous matters, as well as Ford, ...

Treatment with gabapentinoids - drugs such as gabapentin and pregabalin - is not directly associated with an increased risk of self-harm, finds a UK study published by The BMJ today.

Headshot of Dieter Weinand Dieter Weinand, Chairman of the Board of Sibylla Biotech Milan, Italy, May 8, 2025 – Sibylla Biotech today announced the appointment of Dieter Weinand as Chairman of its ...

Pfizer and other leading big pharma companies. His contributions have been essential to the launch of several high-impact medicines, including Lipitor®, Neurontin®, Abilify® and Cipro®.

Among individuals who were prescribed both gabapentin and pregabalin in the observation period ... Janssen, GSK, Novartis, Pfizer, Bayer and Bristol-Myers Squibb, Takeda, Institute for Health Research ...

Pfizer is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years.Shares are down 19% over the past ...

Pfizer decided to discontinue the development of its leading weight management candidate. Despite this setback, the company has a deep pipeline of candidates, especially in oncology. Pfizer's ...

Pfizer's PFE stock has risen 5% since it reported first-quarter results on April 29. While the company beat estimates for earnings, it missed the same for sales. Earnings of 92 cents per share ...

The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer ...

Despite its historical underperformance and declining dividend growth trajectory, Pfizer's 7.63% dividend yield is attractive, making it a compelling income stock candidate. CEO Bourla's strategic ...